Workers check automatic packaging of medicine tablets manufactured at Dr Reddy’s plant in Bachupally, Andra Pradesh state, India (Photographer: Amit Bhargava/Bloomberg News)

Dr. Reddy’s Acquires Portfolio Of 42 ANDAs In U.S.

Drug major Dr Reddy's Laboratories Ltd. on Saturday said it has acquired a portfolio of 42 abbreviated new drug applications—or ANDAs—in the U.S.